Literature DB >> 15642229

Matrix metalloproteinases-2, -9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis.

Shu-hong Ming1, Tie-ying Sun, Wei Xiao, Xiao-mao Xu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642229

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  5 in total

1.  Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients.

Authors:  Magdalena Drzewiecka-Jędrzejczyk; Rafał Wlazeł; Monika Terlecka; Sławomir Jabłoński
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Inhibition of Nonsmall Cell Lung Cancer Cell Migration by Protein Arginine Methyltransferase 1-small Hairpin RNA Through Inhibiting Epithelial-mesenchymal Transition, Extracellular Matrix Degradation, and Src Phosphorylation In Vitro.

Authors:  Ting Zhang; Ge Cui; Yun-Liang Yao; Yue Guo; Qi-Chun Wang; Xi-Ning Li; Wen-Ming Feng
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

3.  PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro.

Authors:  Hong-Xia Bi; Han-Bing Shi; Ting Zhang; Ge Cui
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

4.  Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.

Authors:  Jer-Hwa Chang; Chao-Wen Cheng; Yi-Chieh Yang; Wan-Shen Chen; Wen-Yueh Hung; Jyh-Ming Chow; Pai-Sheng Chen; Michael Hsiao; Wei-Jiunn Lee; Ming-Hsien Chien
Journal:  J Exp Clin Cancer Res       Date:  2018-08-22

5.  Huisheng Oral Solution exerts anti-tumor effects by downregulating tissue factor and inhibiting the expression of metastasis-related factors, CD44, MMP2, and VEGF.

Authors:  Zhonghua Chen; Mei Liu; Kaiyong Xie; Haitao Chen; Jun Wang; Xing Liu
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.